Alan G. Morgan
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Functional analysis of epilepsy-associated GABAA receptor mutations using Caenorhabditis elegans.
Journal: Epilepsia open
Published: January 24, 2024
Tissue distribution of cysteine string protein/DNAJC5 in C. elegans analysed by CRISPR/Cas9-mediated tagging of endogenous DNJ-14.
Journal: Cell and tissue research
Published: August 08, 2023
A Caenorhabditis elegans model of autosomal dominant adult-onset neuronal ceroid lipofuscinosis identifies ethosuximide as a potential therapeutic.
Journal: Human molecular genetics
Published: June 23, 2022
Cysteine string protein alpha accumulates with early pre-synaptic dysfunction in Alzheimer's disease.
Journal: Brain communications
Published: November 10, 2021
Proteomic analysis of dietary restriction in yeast reveals a role for Hsp26 in replicative lifespan extension.
Journal: The Biochemical journal
Published: June 09, 2021
A multiorganism pipeline for antiseizure drug discovery: Identification of chlorothymol as a novel γ-aminobutyric acidergic anticonvulsant.
Journal: Epilepsia
Published: April 24, 2020
The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 26, 2019
A Caenorhabditis elegans assay of seizure-like activity optimised for identifying antiepileptic drugs and their mechanisms of action.
Journal: Journal of neuroscience methods
Published: May 28, 2018
α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a C. elegans model of TDP-43 proteinopathy.
Journal: Neurobiology of disease
Published: April 26, 2018
Last Updated: 09/26/2026